157 related articles for article (PubMed ID: 22699538)
1. Motor assessment in patients with Duchenne muscular dystrophy.
Diniz GP; Lasmar LM; Giannetti JG
Arq Neuropsiquiatr; 2012 Jun; 70(6):416-21. PubMed ID: 22699538
[TBL] [Abstract][Full Text] [Related]
2. Relationship between muscle strength and motor function in Duchenne muscular dystrophy.
Nunes MF; Hukuda ME; Favero FM; Oliveira AB; Voos MC; Caromano FA
Arq Neuropsiquiatr; 2016 Jul; 74(7):530-5. PubMed ID: 27487372
[TBL] [Abstract][Full Text] [Related]
3. Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.
Silva EC; Machado DL; Resende MB; Silva RF; Zanoteli E; Reed UC
Arq Neuropsiquiatr; 2012 Mar; 70(3):191-5. PubMed ID: 22392111
[TBL] [Abstract][Full Text] [Related]
4. Comparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapy.
Parreira SL; Resende MB; Zanoteli E; Carvalho MS; Marie SK; Reed UC
Arq Neuropsiquiatr; 2010 Oct; 68(5):683-8. PubMed ID: 21049175
[TBL] [Abstract][Full Text] [Related]
5. Quantification of muscle strength and motor ability in patients with Duchenne muscular dystrophy on steroid therapy.
Parreira SL; Resende MB; Della Corte Peduto M; Marie SK; Carvalho MS; Reed UC
Arq Neuropsiquiatr; 2007 Jun; 65(2A):245-50. PubMed ID: 17607422
[TBL] [Abstract][Full Text] [Related]
6. Patients with Duchenne and Becker muscular dystrophies are not more asymmetrical than healthy controls on timed performance of upper limb tasks.
Artilheiro MC; Sá CSC; Fávero FM; Caromano FA; Voos MC
Braz J Med Biol Res; 2017 Jul; 50(8):e6031. PubMed ID: 28746422
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
[TBL] [Abstract][Full Text] [Related]
8. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study.
Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F
Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071
[TBL] [Abstract][Full Text] [Related]
9. Cumulative jerk as an outcome measure in nonambulatory Duchenne muscular dystrophy.
Fujii T; Takeshita E; Iwata Y; Yajima H; Nozaki F; Mori M; Kumada T
Brain Dev; 2019 Oct; 41(9):796-802. PubMed ID: 31213334
[TBL] [Abstract][Full Text] [Related]
10. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
[TBL] [Abstract][Full Text] [Related]
11. Analysis of motor and respiratory function in Duchenne muscular dystrophy patients.
Luiz LC; Marson FAL; Bresciani Almeida CC; Toro AADC; Nucci A; Ribeiro JD
Respir Physiol Neurobiol; 2019 Apr; 262():1-11. PubMed ID: 30660861
[TBL] [Abstract][Full Text] [Related]
12. Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.
Duong T; Canbek J; Fernandez-Fernandez A; Henricson E; Birkmeier M; Siener C; Tesi Rocha C; McDonald C; Gordish-Dressman H;
J Neuromuscul Dis; 2022; 9(1):147-159. PubMed ID: 34719507
[TBL] [Abstract][Full Text] [Related]
13. Upper limb function in adults with Duchenne muscular dystrophy.
Bartels B; Pangalila RF; Bergen MP; Cobben NA; Stam HJ; Roebroeck ME
J Rehabil Med; 2011 Sep; 43(9):770-5. PubMed ID: 21826385
[TBL] [Abstract][Full Text] [Related]
14. Alternative instrument for the evaluation of handgrip strength in Duchenne muscular dystrophy.
de Souza MA; Martinez EZ; da Silva Lizzi EA; Cezarani A; de Queiroz Davoli GB; Bená MI; da Rosa Sobreira CF; Mattiello-Sverzut AC
BMC Pediatr; 2022 Jun; 22(1):334. PubMed ID: 35689212
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Hand Strength and Function in Duchenne Muscular Dystrophy and Spinal Muscular Atrophy: Implications for Clinical Trials.
Decostre V; De Antonio M; Servais L; Hogrel JY
J Neuromuscul Dis; 2024; 11(4):777-790. PubMed ID: 38788084
[TBL] [Abstract][Full Text] [Related]
17. Voluntary and magnetically evoked muscle contraction protocol in males with Duchenne muscular dystrophy: Safety, feasibility, reliability, and validity.
Trost JP; Chen M; Stark MM; Hodges JS; Richter S; Lindsay A; Warren GL; Lowe DA; Kimberley TJ
Muscle Nerve; 2021 Aug; 64(2):190-198. PubMed ID: 33974714
[TBL] [Abstract][Full Text] [Related]
18. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.
Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K
Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260
[TBL] [Abstract][Full Text] [Related]
19. Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.
Demir G; Bulut N; Yılmaz Ö; Karaduman A; Alemdaroğlu-Gürbüz İ
Arch Pediatr; 2020 Aug; 27(6):304-309. PubMed ID: 32718814
[TBL] [Abstract][Full Text] [Related]
20. Estimation of muscle strength from actigraph data in Duchenne muscular dystrophy.
Kimura S; Ozasa S; Nomura K; Yoshioka K; Endo F
Pediatr Int; 2014 Oct; 56(5):748-52. PubMed ID: 24689787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
